China National Accord Medicines Corp Ltd (000028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (000028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting CN¥95.44 Million (capex CN¥50.09 Million plus investments CN¥45.35 Million) from operating cash flow of CN¥1.83 Billion. See free cash flow generation of China National Accord Medicines Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 26 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of China National Accord Medicines Corp Ltd.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. See financial agility of China National Accord Medicines Corp Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥476.87 Million | CN¥3.27 Billion | CN¥282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | CN¥457.64 Million | CN¥2.94 Billion | CN¥322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | CN¥665.01 Million | CN¥2.56 Billion | CN¥322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | CN¥514.46 Million | CN¥1.66 Billion | CN¥370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | CN¥324.92 Million | CN¥1.50 Billion | CN¥293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | CN¥301.17 Million | CN¥2.00 Billion | CN¥245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | CN¥380.06 Million | CN¥1.32 Billion | CN¥255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | CN¥217.09 Million | CN¥1.29 Billion | CN¥204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | CN¥275.02 Million | CN¥1.47 Billion | CN¥265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | CN¥226.73 Million | CN¥1.05 Billion | CN¥190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | CN¥150.50 Million | CN¥465.03 Million | CN¥150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | CN¥193.57 Million | CN¥323.96 Million | CN¥193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | CN¥198.97 Million | CN¥227.32 Million | CN¥198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | CN¥177.99 Million | CN¥428.16 Million | CN¥177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | CN¥102.94 Million | CN¥270.85 Million | CN¥102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | CN¥84.98 Million | CN¥246.58 Million | CN¥84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | CN¥71.41 Million | CN¥87.70 Million | CN¥71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | CN¥118.22 Million | CN¥181.73 Million | CN¥118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | CN¥50.62 Million | CN¥148.28 Million | CN¥50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | CN¥14.18 Million | CN¥130.30 Million | CN¥14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | CN¥49.36 Million | CN¥81.22 Million | CN¥49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | CN¥26.90 Million | CN¥28.76 Million | CN¥26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | CN¥35.91 Million | CN¥71.16 Million | CN¥35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | CN¥21.01 Million | CN¥8.52 Million | CN¥21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | CN¥27.54 Million | CN¥22.84 Million | CN¥27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | CN¥10.38 Million | CN¥5.21 Million | CN¥10.38 Million | — |